These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

824 related items for PubMed ID: 23476073

  • 21. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G, Katsikis I.
    Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
    [Abstract] [Full Text] [Related]

  • 22. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
    Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX.
    BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
    [Abstract] [Full Text] [Related]

  • 23. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
    Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A.
    Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
    [Abstract] [Full Text] [Related]

  • 24. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
    Popovska-Dimova Z, Krstevska B.
    Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
    [Abstract] [Full Text] [Related]

  • 25. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?
    Ozkaya E, Cakir E, Cinar M, Kara F, Baser E, Cakir C, Kucukozkan T.
    Gynecol Endocrinol; 2012 Jun; 28(6):468-71. PubMed ID: 22103710
    [Abstract] [Full Text] [Related]

  • 26. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C.
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [Abstract] [Full Text] [Related]

  • 27. [Clinical, hormonal and metabolic characteristics of different phenotypes of polycystic ovary syndrome, in Bulgarian population].
    Kavardzhikova S, Pechlivanov B.
    Akush Ginekol (Sofiia); 2010 Dec; 49(4):32-7. PubMed ID: 20734639
    [Abstract] [Full Text] [Related]

  • 28. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F.
    Front Endocrinol (Lausanne); 2022 Dec; 13():825528. PubMed ID: 35299965
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A, Pérez-López G, Román MM, Martín-Lazaro JF, Lucio Pérez MJ, Asenjo Araque N, Rodríguez-Molina JM, Berrocal Sertucha MC, Aguilar Vilas MV.
    Endocrinol Nutr; 2014 Dec; 61(7):351-8. PubMed ID: 24680383
    [Abstract] [Full Text] [Related]

  • 30. The insulin-resistant phenotype of polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L.
    Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
    [Abstract] [Full Text] [Related]

  • 31. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [Abstract] [Full Text] [Related]

  • 32. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.
    Krentowska A, Kowalska I.
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3464. PubMed ID: 33988288
    [Abstract] [Full Text] [Related]

  • 33. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M, Isaoglu U, Delibas IB, Kadanali S.
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
    [Abstract] [Full Text] [Related]

  • 34. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P, Puukka K, Piltonen TT, Puurunen J, Vanky E, Sundström-Poromaa I, Stener-Victorin E, Lindén Hirschberg A, Ravn P, Skovsager Andersen M, Glintborg D, Mellembakken JR, Ruokonen A, Tapanainen JS, Morin-Papunen LC.
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [Abstract] [Full Text] [Related]

  • 35. Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome.
    Wen X, Wang L, Bai E.
    Front Endocrinol (Lausanne); 2024 Mar; 15():1370578. PubMed ID: 39109080
    [Abstract] [Full Text] [Related]

  • 36. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C, Arriaga M, Arechavaleta-Velasco F, Moran S.
    J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
    [Abstract] [Full Text] [Related]

  • 37. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM, Reeves S.
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [Abstract] [Full Text] [Related]

  • 38. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 39. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC.
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [Abstract] [Full Text] [Related]

  • 40. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kränzlin M, Puder JJ.
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.